Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Comparing the effect of drugs atorvastatin and rosuvastatin on the level of laboratory markers acute coronary syndrome patients

Thu Feb 2 17:32:15 2023

(2022) Comparing the effect of drugs atorvastatin and rosuvastatin on the level of laboratory markers acute coronary syndrome patients. Eurasian Chemical Communications. pp. 894-899. ISSN 2717-0535

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Pharmacotherapy is one of the most important measures for improving the health status of patients, which can play a key role in this regard. The present study was performed to compare the effect of atorvastatin plus rosuvastatin on the value of laboratory markers in CVD patients. This research is a clinical trial study, whose research population consisted of the patients with ACS in Ilam city in 2021. The patients were randomly assigned into three groups: control, intervention A (receiving atorvastatin), and intervention B (receiving rosuvastatin). The patients who met the inclusion criteria were enrolled in the study through available sampling, for all of whom the required tests were performed. The laboratory variables including tests of triglyceride, cholesterol, ALT, AST, ALP, LDH, and LDL, using a single device which was in the laboratory in Ilam city were completed and the documents related to them were considered as assessment criteria. The data analysis was done using SPSS 16 software. The table indicated the comparison of laboratory index scores before and after taking rosuvastatin. According to the findings, in all laboratory indices after taking rosuvastatin, the status of the index has changed significantly to improve the patient's health status (p <0.05). Considering the greater effect of rosuvastatin compared to atorvastatin on improving the laboratory variables, prescription of this drug is suggested for improving the status of CVD patients.

Item Type: Article
Creators:
CreatorsEmail
Balavandi, F.UNSPECIFIED
Neystani, B.UNSPECIFIED
Jamshidbeigi, Y.UNSPECIFIED
Mozafri, A.UNSPECIFIED
Keywords: Atorvastatin rosuvastatin laboratory markers biomarkers risk inflammation metaanalysis quality trials Chemistry
Divisions:
Page Range: pp. 894-899
Journal or Publication Title: Eurasian Chemical Communications
Journal Index: ISI
Volume: 4
Number: 9
Identification Number: https://doi.org/10.22034/ecc.2022.336608.1399
ISSN: 2717-0535
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/3904

Actions (login required)

View Item View Item